Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.46 |
| ▸ | CA1 | P00915 | 3/20 | 0.46 |
| ▸ | CA2 | P00918 | 3/20 | 0.46 |
| ▸ | CA7 | P43166 | 3/20 | 0.46 |
| ▸ | CA9 | Q16790 | 3/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
| ▸ | CA6 | P23280 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | PLAA | Q9Y263 | 6/20 | 0.45 |
| ▸ | ALPG | P10696 | 7/20 | 0.44 |
| ▸ | ALPL | P05186 | 4/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
| ▸ | ALPI | P09923 | 3/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17311212 | 1.00 | CA12 (0.46) | CA12CA1CA2CA7CA9 | |
| SCHEMBL25222935 | 0.84 | PKM (0.53) | CA2CA9KDM4EGAAPOLB | |
| SCHEMBL28214996 | 0.80 | NPC1 (0.48) | L3MBTL1KDM4EGAAPOLBMAPT | |
| SCHEMBL26922809 | 0.78 | KMO (0.47) | KDM4EPOLBHDAC6 | |
| SCHEMBL13977643 | 0.77 | PTPN1 (0.56) | KDM4EPOLBMAPTTDP1MEN1 | |
| SCHEMBL28984896 | 0.77 | GSK3B (0.52) | L3MBTL1GAAMAPTHDAC6TDP1 | |
| SCHEMBL14466949 | 0.75 | GSK3B (0.52) | CA1CA2L3MBTL1KDM4EPOLB | |
| SCHEMBL34473284 | 0.75 | MEN1 (0.38) | CA2CA9KDM4EPOLBMAPT | |
| SCHEMBL13857466 | 0.75 | GSK3B (0.55) | CA1CA2KDM4EPOLBHDAC6 | |
| SCHEMBL13817452 | 0.75 | NPC1 (0.50) | CA1CA2MAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250000091-A1 | GRAFTABLE BIOCIDAL LINKERS AND POLYMERS AND USES THEREOF | DEBOGY MOLECULAR, INC. (US) | 2025-01-02 | — | — | US | disclosed |
| WO-2023102567-A2 | GRAFTABLE BIOCIDAL LINKERS AND POLYMERS AND USES THEREOF | DEBOGY MOLECULAR, INC. (US) | 2023-06-08 | — | — | WO | disclosed |
| CN-115988962-A | Graftable biocidal linkers and polymers and uses thereof | 德保吉分子公司 | 2023-04-18 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250000091-A1 | GRAFTABLE BIOCIDAL LINKERS AND POLYMERS AND USES THEREOF | ALG1, BSG, BTD | CA12 1413/4885CA1 1155/4885CA2 3224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.